MENU
BMED
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

BMED stock forecast, quote, news & analysis

The investment seeks to maximize total return... Show more

Category: #Health
BMED
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for BMED with price predictions
Jun 04, 2026

BMED in +2.92% Uptrend, growing for three consecutive days on June 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BMED advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BMED's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 22, 2026. You may want to consider a long position or call options on BMED as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BMED just turned positive on May 21, 2026. Looking at past instances where BMED's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

BMED moved above its 50-day moving average on June 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where BMED's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for BMED moved below the 200-day moving average on May 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BMED broke above its upper Bollinger Band on May 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BMED entered a downward trend on May 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Medtronic plc (NYSE:MDT), McKesson Corp (NYSE:MCK).

Industry description

The investment seeks to maximize total return. Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.

Market Cap

The average market capitalization across the iShares Health Innovation Active ETF ETF is 38.21B. The market cap for tickers in the group ranges from 64.17M to 560.33B. JNJ holds the highest valuation in this group at 560.33B. The lowest valued company is TCRX at 64.17M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Health Innovation Active ETF ETF was 0%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was -6%. GKOS experienced the highest price growth at 21%, while NYXH experienced the biggest fall at -53%.

Volume

The average weekly volume growth across all stocks in the iShares Health Innovation Active ETF ETF was 6%. For the same stocks of the ETF, the average monthly volume growth was 4% and the average quarterly volume growth was 17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 67
Price Growth Rating: 53
SMR Rating: 79
Profit Risk Rating: 82
Seasonality Score: 30 (-100 ... +100)
View a ticker or compare two or three
BMED
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
BlackRock ETF Trust100 BELLEVUE PARKWAY
Phone
N/A
Web
www.blackrock.com
BMED in +2.92% Uptrend, growing for three consecutive days on June 04, 2026